Bouten CVC - Search Results

1

Inconsistency in Graft Outcome of Bilayered Bioresorbable Supramolecular Arterial Scaffolds in Rats.

Duijvelshoff R, di Luca A, van Haaften EE, Dekker S, Söntjens SHM, Janssen HM, Smits AIPM, Dankers PYW, Bouten CVC. Duijvelshoff R, et al. Among authors: bouten cvc. Tissue Eng Part A. 2021 Jul;27(13-14):894-904. doi: 10.1089/ten.TEA.2020.0185. Epub 2020 Oct 5. Tissue Eng Part A. 2021. PMID: 32873211

2

Monitoring local cell viability in engineered tissues: a fast, quantitative, and nondestructive approach.

Breuls RG, Mol A, Petterson R, Oomens CW, Baaijens FP, Bouten CV. Breuls RG, et al. Tissue Eng. 2003 Apr;9(2):269-81. doi: 10.1089/107632703764664738. Tissue Eng. 2003. PMID: 12740089

3

The role of collagen cross-links in biomechanical behavior of human aortic heart valve leaflets--relevance for tissue engineering.

Balguid A, Rubbens MP, Mol A, Bank RA, Bogers AJ, van Kats JP, de Mol BA, Baaijens FP, Bouten CV. Balguid A, et al. Tissue Eng. 2007 Jul;13(7):1501-11. doi: 10.1089/ten.2006.0279. Tissue Eng. 2007. PMID: 17518750 Free article.

4

The influence of serum-free culture conditions on skeletal muscle differentiation in a tissue-engineered model.

Gawlitta D, Boonen KJ, Oomens CW, Baaijens FP, Bouten CV. Gawlitta D, et al. Tissue Eng Part A. 2008 Jan;14(1):161-71. doi: 10.1089/ten.a.2007.0095. Tissue Eng Part A. 2008. PMID: 18333814

5

Tailoring fiber diameter in electrospun poly(epsilon-caprolactone) scaffolds for optimal cellular infiltration in cardiovascular tissue engineering.

Balguid A, Mol A, van Marion MH, Bank RA, Bouten CV, Baaijens FP. Balguid A, et al. Tissue Eng Part A. 2009 Feb;15(2):437-44. doi: 10.1089/ten.tea.2007.0294. Tissue Eng Part A. 2009. PMID: 18694294

6

Intermittent straining accelerates the development of tissue properties in engineered heart valve tissue.

Rubbens MP, Mol A, Boerboom RA, Bank RA, Baaijens FP, Bouten CV. Rubbens MP, et al. Tissue Eng Part A. 2009 May;15(5):999-1008. doi: 10.1089/ten.tea.2007.0396. Tissue Eng Part A. 2009. PMID: 18795866

7

Straining mode-dependent collagen remodeling in engineered cardiovascular tissue.

Rubbens MP, Mol A, van Marion MH, Hanemaaijer R, Bank RA, Baaijens FP, Bouten CV. Rubbens MP, et al. Tissue Eng Part A. 2009 Apr;15(4):841-9. doi: 10.1089/ten.tea.2008.0185. Tissue Eng Part A. 2009. PMID: 18847358

8

Tissue engineering of heart valves: advances and current challenges.

Mol A, Smits AI, Bouten CV, Baaijens FP. Mol A, et al. Expert Rev Med Devices. 2009 May;6(3):259-75. doi: 10.1586/erd.09.12. Expert Rev Med Devices. 2009. PMID: 19419284 Review.

9

Tissue-engineered heart valves develop native-like collagen fiber architecture.

Cox MA, Kortsmit J, Driessen N, Bouten CV, Baaijens FP. Cox MA, et al. Tissue Eng Part A. 2010 May;16(5):1527-37. doi: 10.1089/ten.TEA.2009.0263. Tissue Eng Part A. 2010. PMID: 20001249

10

Substrates for cardiovascular tissue engineering.

Bouten CV, Dankers PY, Driessen-Mol A, Pedron S, Brizard AM, Baaijens FP. Bouten CV, et al. Adv Drug Deliv Rev. 2011 Apr 30;63(4-5):221-41. doi: 10.1016/j.addr.2011.01.007. Epub 2011 Jan 25. Adv Drug Deliv Rev. 2011. PMID: 21277921 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

254 results

Search Page

Filters